What is the medical term for congenital breast gigantomastia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medical Term for Congenital Breast Gigantism

The medical term for congenital breast gigantism is juvenile gigantomastia (also called virginal hypertrophy or virginal gigantomastia).

Definition and Clinical Context

Juvenile gigantomastia is a benign disorder characterized by massive, bilateral (or occasionally unilateral) breast enlargement that occurs during adolescence, typically presenting during puberty 1. This condition represents a volume anomaly of the breast in teenagers that is distinct from gestational gigantomastia, which occurs during pregnancy 2, 3.

Key Distinguishing Features

The term "juvenile" or "virginal" specifically denotes:

  • Onset during adolescence (typically ages 10-17 years)
  • Occurs before pregnancy (hence "virginal")
  • Congenital/developmental etiology rather than acquired

This distinguishes it from:

  • Gestational gigantomastia: massive breast enlargement during pregnancy 2, 3
  • Adult-onset macromastia: less severe breast hypertrophy in adults
  • Gynecomastia: male breast enlargement 4

Clinical Presentation

Juvenile gigantomastia manifests as:

  • Rapid, massive breast tissue proliferation during puberty
  • Physical symptoms: pain, impaired spinal posture, shoulder girdle problems
  • Psychological distress and social impairment 1, 5
  • Can be unilateral or bilateral 1

Pathophysiology

The underlying mechanism involves:

  • Hormonal hypersensitivity (particularly to estrogen and progesterone)
  • High expression of estrogen and progesterone receptors (up to 70%) in breast tissue 6
  • Benign glandular hyperplasia with fibrosis, hamartomas, and fibroadenomas 6

Important Clinical Caveat

The condition has a high recurrence rate when treated in young patients (ages 10-12 years), with many requiring secondary surgery 1. Older adolescent patients (age 17+) treated with reduction mammaplasty alone may have more stable results without recurrence 1.

Related Questions

In a 70-year-old man with sudden gynecomastia, which medication is most likely responsible?
What is the appropriate evaluation and management for an adult male with acute onset gynecomastia?
How should breast edema during pregnancy be evaluated and managed?
Can elevated estradiol from aromatization of testosterone replacement therapy be the cause of his symptoms such as gynecomastia, mood changes, decreased libido, or fluid retention?
What is the likely cause and recommended management for bilateral breast enlargement in a 13‑day‑old male infant?
Is external defibrillation safe in a patient with a left ventricular thrombus, and should a trans‑venous implantable cardioverter‑defibrillator be placed?
What is the appropriate management for a patient with sinus rhythm 48–123 bpm, frequent premature atrial contractions (~1200), occasional premature ventricular contractions (~194), no tachyarrhythmias or significant pauses, and symptoms occurring during normal sinus rhythm?
What are the risks of performing leg massage in a patient with nephrotic syndrome who has or may have deep vein thrombosis?
What is the recommended management for an adult with established coronary artery disease and typical risk factors such as hypertension, hyperlipidemia, diabetes, smoking, or a family history of premature heart disease?
In a systemic lupus erythematosus (SLE) patient with intermittent pleuritic chest pain and a history of myocarditis, what does an elevated erythrocyte sedimentation rate (ESR) indicate?
Which selective serotonin reuptake inhibitors have the shortest elimination half-lives?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.